- Home
- HOOK vs MFI Comparison
HOOK vs MFI Comparison
Compare HOOK & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- MFI
- Stock Information
- Founded
- HOOK 2011
- MFI 2002
- Country
- HOOK United States
- MFI Hong Kong
- Employees
- HOOK N/A
- MFI N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- MFI
- Sector
- HOOK Health Care
- MFI
- Exchange
- HOOK Nasdaq
- MFI NYSE
- Market Cap
- HOOK 9.3M
- MFI 8.2M
- IPO Year
- HOOK 2019
- MFI 2024
- Fundamental
- Price
- HOOK $1.59
- MFI $0.86
- Analyst Decision
- HOOK Buy
- MFI
- Analyst Count
- HOOK 4
- MFI 0
- Target Price
- HOOK $10.67
- MFI N/A
- AVG Volume (30 Days)
- HOOK 207.3K
- MFI 495.9K
- Earning Date
- HOOK 05-15-2025
- MFI 06-10-2025
- Dividend Yield
- HOOK N/A
- MFI N/A
- EPS Growth
- HOOK N/A
- MFI N/A
- EPS
- HOOK N/A
- MFI N/A
- Revenue
- HOOK $9,351,000.00
- MFI $3,358,264.00
- Revenue This Year
- HOOK N/A
- MFI N/A
- Revenue Next Year
- HOOK N/A
- MFI N/A
- P/E Ratio
- HOOK N/A
- MFI N/A
- Revenue Growth
- HOOK N/A
- MFI N/A
- 52 Week Low
- HOOK $0.72
- MFI $0.51
- 52 Week High
- HOOK $9.09
- MFI $1.58
- Technical
- Relative Strength Index (RSI)
- HOOK 59.36
- MFI N/A
- Support Level
- HOOK $1.45
- MFI N/A
- Resistance Level
- HOOK $1.62
- MFI N/A
- Average True Range (ATR)
- HOOK 0.16
- MFI 0.00
- MACD
- HOOK -0.00
- MFI 0.00
- Stochastic Oscillator
- HOOK 67.57
- MFI 0.00
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About MFI MF INTERNATIONAL LIMITED
mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.